Sources | Names Used |
---|---|
CTRPv2 | compound 1B |
PharmacoGx | compound 1B |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WDR59 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
mRNA | TUBAL3 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
mRNA | NMD3 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
mRNA | TNFRSF10C | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
mRNA | PDCD11 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.03 |
mRNA | TIMM10 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
mRNA | PCDHB5 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
mRNA | CST3 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
mRNA | CYB5D1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
mRNA | PPT2 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.03 |